Pharming Group (PHAR) stock valuation

$13.02 Nov 10, 2026 · market cap $9.1B

21% below fair value
i

Pharming Group trades at $13. Our two models put it at $8.47–$25 (base $17): 21% below the base.

Cash Flow $25 · Damodaran $8.47 · models run Nov 10, 2026

1 of 121 tracked investors holds it · Q2 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate PHARCreate free account →

Full open-source research report for PHAR on DeepValues Research (CC BY 4.0)